KR20150027009A - 항균 효과를 갖는 조성물의 제조에서의 파촐리 추출물의 용도 - Google Patents
항균 효과를 갖는 조성물의 제조에서의 파촐리 추출물의 용도 Download PDFInfo
- Publication number
- KR20150027009A KR20150027009A KR20140116965A KR20140116965A KR20150027009A KR 20150027009 A KR20150027009 A KR 20150027009A KR 20140116965 A KR20140116965 A KR 20140116965A KR 20140116965 A KR20140116965 A KR 20140116965A KR 20150027009 A KR20150027009 A KR 20150027009A
- Authority
- KR
- South Korea
- Prior art keywords
- extract
- use according
- plectranthus amboinicus
- composition
- lau
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Ceased
Links
- 239000000284 extract Substances 0.000 title claims abstract description 53
- 239000000203 mixture Substances 0.000 title claims abstract description 36
- 230000000694 effects Effects 0.000 title description 3
- 238000002360 preparation method Methods 0.000 title description 3
- 241000222666 Boerhavia diffusa Species 0.000 title 1
- 235000011751 Pogostemon cablin Nutrition 0.000 title 1
- 235000004094 Coleus amboinicus Nutrition 0.000 claims abstract description 44
- 238000000034 method Methods 0.000 claims abstract description 19
- 206010000496 acne Diseases 0.000 claims abstract description 18
- 208000002874 Acne Vulgaris Diseases 0.000 claims abstract description 17
- 244000005700 microbiome Species 0.000 claims abstract description 17
- 239000003814 drug Substances 0.000 claims abstract description 13
- 208000015181 infectious disease Diseases 0.000 claims abstract description 13
- 230000002401 inhibitory effect Effects 0.000 claims abstract description 10
- 241000186427 Cutibacterium acnes Species 0.000 claims abstract description 9
- 229940055019 propionibacterium acne Drugs 0.000 claims abstract description 9
- 241000191967 Staphylococcus aureus Species 0.000 claims abstract description 8
- 238000004519 manufacturing process Methods 0.000 claims abstract description 5
- 241000589517 Pseudomonas aeruginosa Species 0.000 claims abstract description 4
- 241001184136 Plectranthus amboinicus Species 0.000 claims abstract 11
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 77
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims description 33
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 24
- 239000000287 crude extract Substances 0.000 claims description 22
- 241000894006 Bacteria Species 0.000 claims description 14
- 241001664469 Tibicina haematodes Species 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 13
- 239000000843 powder Substances 0.000 claims description 11
- 241000196324 Embryophyta Species 0.000 claims description 10
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 claims description 8
- 239000002537 cosmetic Substances 0.000 claims description 5
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims description 4
- 229960004889 salicylic acid Drugs 0.000 claims description 4
- 235000014347 soups Nutrition 0.000 claims description 4
- 241000131460 Plectranthus Species 0.000 claims description 3
- 241000186429 Propionibacterium Species 0.000 claims description 3
- 241000589516 Pseudomonas Species 0.000 claims description 3
- 241000191940 Staphylococcus Species 0.000 claims description 3
- 241000353097 Molva molva Species 0.000 claims description 2
- 206010028980 Neoplasm Diseases 0.000 claims description 2
- 230000003110 anti-inflammatory effect Effects 0.000 claims description 2
- 201000011510 cancer Diseases 0.000 claims description 2
- 239000000645 desinfectant Substances 0.000 claims description 2
- 241000894007 species Species 0.000 claims 3
- 239000000419 plant extract Substances 0.000 claims 2
- 244000146462 Centella asiatica Species 0.000 claims 1
- 235000004032 Centella asiatica Nutrition 0.000 claims 1
- 239000010802 sludge Substances 0.000 claims 1
- 230000000813 microbial effect Effects 0.000 abstract description 5
- 244000119308 Coleus amboinicus Species 0.000 description 33
- 239000003480 eluent Substances 0.000 description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 239000003242 anti bacterial agent Substances 0.000 description 5
- 230000002757 inflammatory effect Effects 0.000 description 5
- 238000004440 column chromatography Methods 0.000 description 4
- 229940079593 drug Drugs 0.000 description 4
- 238000000605 extraction Methods 0.000 description 4
- 208000024891 symptom Diseases 0.000 description 4
- 241001465754 Metazoa Species 0.000 description 3
- 229940088710 antibiotic agent Drugs 0.000 description 3
- 229940059958 centella asiatica extract Drugs 0.000 description 3
- 238000010828 elution Methods 0.000 description 3
- 239000000706 filtrate Substances 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- ULGZDMOVFRHVEP-RWJQBGPGSA-N Erythromycin Chemical compound O([C@@H]1[C@@H](C)C(=O)O[C@@H]([C@@]([C@H](O)[C@@H](C)C(=O)[C@H](C)C[C@@](C)(O)[C@H](O[C@H]2[C@@H]([C@H](C[C@@H](C)O2)N(C)C)O)[C@H]1C)(C)O)CC)[C@H]1C[C@@](C)(OC)[C@@H](O)[C@H](C)O1 ULGZDMOVFRHVEP-RWJQBGPGSA-N 0.000 description 2
- 241000233866 Fungi Species 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 230000000844 anti-bacterial effect Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 238000004587 chromatography analysis Methods 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000006378 damage Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 210000003780 hair follicle Anatomy 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000011347 resin Substances 0.000 description 2
- 229920005989 resin Polymers 0.000 description 2
- 210000003491 skin Anatomy 0.000 description 2
- 241000195493 Cryptophyta Species 0.000 description 1
- 241000206602 Eukaryota Species 0.000 description 1
- 241000282326 Felis catus Species 0.000 description 1
- IECPWNUMDGFDKC-UHFFFAOYSA-N Fusicsaeure Natural products C12C(O)CC3C(=C(CCC=C(C)C)C(O)=O)C(OC(C)=O)CC3(C)C1(C)CCC1C2(C)CCC(O)C1C IECPWNUMDGFDKC-UHFFFAOYSA-N 0.000 description 1
- 206010061217 Infestation Diseases 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 241000283973 Oryctolagus cuniculus Species 0.000 description 1
- 208000012868 Overgrowth Diseases 0.000 description 1
- 241001521757 Propionibacterium sp. Species 0.000 description 1
- 241000589774 Pseudomonas sp. Species 0.000 description 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 1
- 206010039792 Seborrhoea Diseases 0.000 description 1
- 241001147693 Staphylococcus sp. Species 0.000 description 1
- 239000004098 Tetracycline Substances 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229940121375 antifungal agent Drugs 0.000 description 1
- 239000003429 antifungal agent Substances 0.000 description 1
- 239000003443 antiviral agent Substances 0.000 description 1
- 230000001580 bacterial effect Effects 0.000 description 1
- 230000003115 biocidal effect Effects 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 229940063193 cleocin Drugs 0.000 description 1
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 208000031513 cyst Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 229960003276 erythromycin Drugs 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 229940048400 fucidin Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 229940127249 oral antibiotic Drugs 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- HJHVQCXHVMGZNC-JCJNLNMISA-M sodium;(2z)-2-[(3r,4s,5s,8s,9s,10s,11r,13r,14s,16s)-16-acetyloxy-3,11-dihydroxy-4,8,10,14-tetramethyl-2,3,4,5,6,7,9,11,12,13,15,16-dodecahydro-1h-cyclopenta[a]phenanthren-17-ylidene]-6-methylhept-5-enoate Chemical compound [Na+].O[C@@H]([C@@H]12)C[C@H]3\C(=C(/CCC=C(C)C)C([O-])=O)[C@@H](OC(C)=O)C[C@]3(C)[C@@]2(C)CC[C@@H]2[C@]1(C)CC[C@@H](O)[C@H]2C HJHVQCXHVMGZNC-JCJNLNMISA-M 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229940124530 sulfonamide Drugs 0.000 description 1
- 150000003456 sulfonamides Chemical class 0.000 description 1
- 229960002180 tetracycline Drugs 0.000 description 1
- 229930101283 tetracycline Natural products 0.000 description 1
- 235000019364 tetracycline Nutrition 0.000 description 1
- 150000003522 tetracyclines Chemical class 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/532—Agastache, e.g. giant hyssop
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/192—Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/23—Apiaceae or Umbelliferae (Carrot family), e.g. dill, chervil, coriander or cumin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/10—Anti-acne agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/02—Local antiseptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q17/00—Barrier preparations; Preparations brought into direct contact with the skin for affording protection against external influences, e.g. sunlight, X-rays or other harmful rays, corrosive materials, bacteria or insect stings
- A61Q17/005—Antimicrobial preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/10—Washing or bathing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/333—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using mixed solvents, e.g. 70% EtOH
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/39—Complex extraction schemes, e.g. fractionation or repeated extraction steps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/51—Concentration or drying of the extract, e.g. Lyophilisation, freeze-drying or spray-drying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/50—Methods involving additional extraction steps
- A61K2236/53—Liquid-solid separation, e.g. centrifugation, sedimentation or crystallization
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Dermatology (AREA)
- Medical Informatics (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Birds (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Emergency Medicine (AREA)
- Medicines Containing Plant Substances (AREA)
- Cosmetics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| TW102131723A TWI663982B (zh) | 2013-09-03 | 2013-09-03 | 到手香萃取物用於製備具抗微生物功效組合物之用途 |
| TW102131723 | 2013-09-03 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20150027009A true KR20150027009A (ko) | 2015-03-11 |
Family
ID=52668165
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR20140116965A Ceased KR20150027009A (ko) | 2013-09-03 | 2014-09-03 | 항균 효과를 갖는 조성물의 제조에서의 파촐리 추출물의 용도 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20150079202A1 (enExample) |
| JP (2) | JP2015091772A (enExample) |
| KR (1) | KR20150027009A (enExample) |
| CN (1) | CN104415089B (enExample) |
| IN (1) | IN2014DE02523A (enExample) |
| MY (1) | MY180113A (enExample) |
| TW (1) | TWI663982B (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2018014805A1 (en) * | 2016-07-17 | 2018-01-25 | ONENESS BIOTECH CO., Ltd | Topical formulation for promoting wound healing |
| EP3893908A1 (en) | 2018-12-10 | 2021-10-20 | University of Pretoria | Anti-acne pharmaceutical compositions |
| US20250195595A1 (en) * | 2023-12-15 | 2025-06-19 | Oneness Biotech Co., Ltd. | Topical formulation for wound healing |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH04217906A (ja) * | 1990-01-19 | 1992-08-07 | Shiseido Co Ltd | 皮膚外用剤 |
| DE19654635C1 (de) * | 1996-12-28 | 1998-01-08 | Singh Verma Shyam B | Kosmetische Zubereitungen enthaltend Extrakte von Phyllanthus emblica und Centella asiatica |
| AU2001255487A1 (en) * | 2000-04-21 | 2001-11-07 | Nature's Cure | Salicylic acid acne spray formulations and methods for treating acne with same |
| JP4589483B2 (ja) * | 2000-05-12 | 2010-12-01 | 花王株式会社 | ニキビ予防治療剤 |
| GB0403702D0 (en) * | 2004-02-19 | 2004-03-24 | Boots Co Plc | Skincare compositions |
| TWI361074B (en) * | 2005-12-22 | 2012-04-01 | Dev Center Biotechnology | Plant extracts for enhancing healing of wounds,and the preparation process and use thereof |
| US8449924B2 (en) * | 2007-08-29 | 2013-05-28 | Development Center For Biotechnology | Process for the preparation of plant extracts for treating skin disorders and enhancing healing of wounds |
| WO2012131348A1 (en) * | 2011-03-31 | 2012-10-04 | Evocutis Plc | Salicylic acid topical formulation |
| TWI501772B (zh) * | 2011-11-22 | 2015-10-01 | Oneness Biotech Co | 具抗關節炎活性的到手香精萃物 |
-
2013
- 2013-09-03 TW TW102131723A patent/TWI663982B/zh active
-
2014
- 2014-09-02 CN CN201410442909.2A patent/CN104415089B/zh active Active
- 2014-09-03 KR KR20140116965A patent/KR20150027009A/ko not_active Ceased
- 2014-09-03 US US14/475,888 patent/US20150079202A1/en not_active Abandoned
- 2014-09-03 IN IN2523DE2014 patent/IN2014DE02523A/en unknown
- 2014-09-03 MY MYPI2014002547A patent/MY180113A/en unknown
- 2014-09-03 JP JP2014179539A patent/JP2015091772A/ja active Pending
-
2019
- 2019-07-18 JP JP2019132598A patent/JP2019178170A/ja not_active Withdrawn
Also Published As
| Publication number | Publication date |
|---|---|
| JP2019178170A (ja) | 2019-10-17 |
| TW201509428A (zh) | 2015-03-16 |
| TWI663982B (zh) | 2019-07-01 |
| HK1208149A1 (en) | 2016-02-26 |
| MY180113A (en) | 2020-11-23 |
| CN104415089B (zh) | 2021-04-20 |
| JP2015091772A (ja) | 2015-05-14 |
| CN104415089A (zh) | 2015-03-18 |
| US20150079202A1 (en) | 2015-03-19 |
| IN2014DE02523A (enExample) | 2015-06-26 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP2775838B1 (en) | Aqueous antimicrobial composition containing coniferous resin acids | |
| KR20210018735A (ko) | 어성초 복합 추출물을 유효성분으로 포함하는 항여드름 및 항염증 조성물 | |
| JPH06279256A (ja) | 皮膚外用剤 | |
| JP2019178170A (ja) | 抗微生物作用を備えた組成物の製造のためのパチョリ抽出物の使用 | |
| KR101934794B1 (ko) | 고욤잎 및 포도송이 가지의 혼합 추출물을 유효성분으로 함유하는 아토피 피부염의 예방, 개선 또는 치료용 조성물 | |
| CN102196813B (zh) | 包含印楝和苦瓜或芝麻的提取物的局部组合物 | |
| KR102059392B1 (ko) | 정향, 히비스커스, 및 코코넛 추출물을 유효성분으로 포함하는 항균 및 항진균 조성물 | |
| CN108451799A (zh) | 一种洗手液及其制备方法 | |
| KR101392808B1 (ko) | 식물 추출물 또는 이의 분획물을 포함하는 항균용 조성물 | |
| EP3119206A1 (en) | Extracts of santolina chamaecyparissus | |
| Kacemi et al. | Bee Pollen as a Source of Pharmaceuticals: Where Are We Now? | |
| WO2013191565A1 (en) | Antimicrobial composition and its method of use | |
| US8557309B2 (en) | Antimicrobial composition based on botanical extracts from oil palm vegetation liquor | |
| US4584198A (en) | Therapeutic compositions having antibacteric activity comprising a fraction extracted from camomile flowers and process for the preparation of said fraction | |
| CN101766731B (zh) | 茶多酚抗痤疮外用制剂 | |
| JP5972732B2 (ja) | 抗菌剤及び皮膚外用剤 | |
| KR102488864B1 (ko) | 가자 추출물 및 애엽 추출물을 함유하는 피부세균총의 생장 조절 또는 피부 면역 강화용 조성물 | |
| KR20170065187A (ko) | 티트리 잎 복합 추출물을 함유하는 여드름 개선용 화장료 조성물 | |
| KR101803148B1 (ko) | 톱니모자반 추출물 또는 이의 분획물을 유효성분으로 포함하는 항균 조성물 | |
| KR20210020817A (ko) | 망고스틴 추출물을 포함하는 여드름 원인균에 대한 항균용 조성물 및 이를 포함하는 여드름의 예방 또는 치료용 제제 | |
| EP2793917A1 (de) | Extrakt aus rhus copallina als arzneimittel | |
| US9980998B2 (en) | Medicinal composition having antibiotic, anti-inflammatory, and wound healing activity | |
| KR20200106282A (ko) | 아토피 피부염 개선용 피부 외용제 조성물 | |
| KR20210086768A (ko) | 등수국 추출물 또는 이의 분획물을 유효성분으로 함유하는 항균용 조성물 | |
| KR102141462B1 (ko) | 석창포 추출물 및 후박 추출물을 유효성분으로 포함하는 항균용 조성물 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PA0109 | Patent application |
Patent event code: PA01091R01D Comment text: Patent Application Patent event date: 20140903 |
|
| PG1501 | Laying open of application | ||
| PA0201 | Request for examination |
Patent event code: PA02012R01D Patent event date: 20190807 Comment text: Request for Examination of Application Patent event code: PA02011R01I Patent event date: 20140903 Comment text: Patent Application |
|
| E902 | Notification of reason for refusal | ||
| PE0902 | Notice of grounds for rejection |
Comment text: Notification of reason for refusal Patent event date: 20200903 Patent event code: PE09021S01D |
|
| E601 | Decision to refuse application | ||
| PE0601 | Decision on rejection of patent |
Patent event date: 20201127 Comment text: Decision to Refuse Application Patent event code: PE06012S01D Patent event date: 20200903 Comment text: Notification of reason for refusal Patent event code: PE06011S01I |